• The company has supported the launch of Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo using the SSi Mantra 3.0 surgical robotic system.
• The program began with a robotic-assisted LIMA takedown, performed by SS Innovations founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva.
• Kings Hospital has completed more than 25 robotic procedures in three weeks, according to a recent company video describing the program’s early activity.
• SS Innovations reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter.
• The company’s second-quarter revenue reached $13.9 million, while robotic procedures increased 143% year over year to 2,528, pointing to rising utilization of the company’s installed base.
• The next major corporate milestone is regulatory expansion, with SS Innovations pursuing U.S. FDA clearance and European CE marking for the SSi Mantra system.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is helping write a new chapter in Sri Lanka’s cardiac-surgery sector with the launch of the country’s first robotic cardiac surgery program at Kings Hospital Colombo, using the SSi Mantra 3.0 surgical robotic system.

The program began with a robotic-assisted left internal mammary artery (“LIMA”) takedown performed by Dr. Sudhir Srivastava, founder and chairman of SS Innovations, together with Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. The development was highlighted in a recent video from SS Innovations, which described the introduction of robotic cardiac surgery as an effort to expand access to minimally invasive procedures in Sri Lanka (https://ibn.fm/jAzkf). The hospital has already completed more than 25 robotic procedures during the first three weeks of the program.

The development gives SS Innovations another international reference point for its SSi Mantra platform as the company works to expand beyond its established Indian market.

Kings Hospital’s adoption of the SSi Mantra 3.0 is intended to expand the hospital’s capacity for robotic-assisted procedures while developing local expertise in the technology. The system incorporates stereoscopic 3D 4K visualization and robotic instrument control, allowing surgeons to perform procedures through smaller access points where clinically appropriate.

The Sri Lankan program also illustrates another aspect of robotic surgery: the transfer of specialized capabilities across national healthcare systems. For patients, greater availability of advanced procedures locally can reduce the need to travel overseas for selected treatments. For hospitals, installing robotic platforms can create a foundation for surgeon training and the development of additional minimally invasive programs.

SS Innovations has also developed its technology with future telesurgery applications in mind. To date the company has completed more than 25 cardiac telesurgeries using SSi Mantra. Telesurgery remains an emerging application requiring appropriate regulatory, clinical and technical infrastructure, rather than a mature commercial revenue stream for the company.

The Sri Lankan installation comes as SS Innovations reports increasing activity across its broader installed base.

A recent analysis by Lucid Capital Markets found that the company placed 30 SSi Mantra systems during the second quarter of 2026, ahead of the analyst’s expectation of 25. Cumulative installations reached 224 systems across 12 countries, compared with 194 at the end of the first quarter. First-half placements totaled 56 systems, versus 38 during the first half of 2025.

The company’s financial results provide another indication of the commercial trajectory. Second-quarter revenue reached $13.9 million, an increase of 39% from the year-earlier period. System sales rose 41% to $12.4 million, while gross margin was 50.9%.

More significant for the economics of a surgical robotics platform may be the increase in procedures performed on installed systems. SS Innovations reported 2,528 robotic surgeries during the second quarter, representing a 143% year-over-year increase. Cumulative procedures performed using SSi Mantra reached 12,272, including 637 cardiac procedures and 222 pediatric cases.

A larger installed base combined with rising procedure volumes can create opportunities for recurring revenue from instruments, accessories and other consumables used during surgery. That model is particularly relevant in India, where SS Innovations has spent several years establishing its presence and building a network of hospitals using SSi Mantra.

SS Innovations has often positioned SSi Mantra as a cost-conscious alternative in surgical robotics, but affordability is only one component of the company’s competitive proposition. The system is designed as a comprehensive robotic surgical platform capable of supporting multiple specialties, with high-definition three-dimensional visualization and multi-jointed instruments intended to give surgeons greater control during minimally invasive procedures.

The company’s international expansion now faces a more conventional biotechnology- and medical-device-style hurdle: regulatory approval. SS Innovations has submitted a 510(k) application to the U.S. Food and Drug Administration for SSi Mantra and is pursuing CE marking for the European Union. The company now expects FDA clearance by end of Q1 2027. Its target for CE marking remains the end of 2026.

For more information, visit the company’s website at www.SSInnovations.com.

NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

• WRAP(R) is expanding beyond individual public safety technologies by integrating training, situational awareness, response capabilities, and continuous learning into a broader platform.
• Its relationship with WOFT Charities and Florida’s Teacher Safety Training Program demonstrates how WRAP’s training methodology can extend into new professional environments.
• The company’s Wrap Tactics(TM) learning management system could provide a scalable foundation for certification, recurring training, and broader adoption across education, private security, military, and other markets.

Public safety technology is increasingly moving beyond individual products as organizations seek solutions that combine technology with training, situational awareness, real-world scenarios, and continuous professional development. Wrap Technologies (NASDAQ: WRAP) is positioning itself at the intersection of these capabilities as it works to expand its public safety platform across a broader range of applications.

Known for its public safety platform and training capabilities, WRAP is increasingly applying its expertise beyond traditional law enforcement. That strategy was recently highlighted through the company’s selection by WOFT Charities to support Florida’s Teacher Safety Training Program, an initiative supported by approximately $475,000 in state funding. The full appropriation is not a direct award to WRAP and should not be read as future WRAP revenue.

The program is designed to provide practical safety and preparedness training for teachers, administrators, and other school personnel, with WRAP contributing methodologies centered on situational awareness, threat recognition, early intervention, and de-escalation. The state funding was awarded to WOFT, with WRAP compensated for the services it provides under the program.

For investors, however, the significance of the initiative may extend beyond the immediate engagement.

“Everything starts with awareness,” Jared Novick, President and Chief Operating Officer of WRAP, said, emphasizing the importance of recognizing threat indicators and understanding changing circumstances before situations escalate.

That philosophy is central to WRAP’s broader approach. Rather than viewing training as a standalone service, the company is integrating instruction, scenario-based learning, technology, and response capabilities into a connected ecosystem designed to help organizations prepare for and manage complex situations.

The WOFT relationship provides an early example of how that model can be applied outside traditional law enforcement. WRAP has exclusive access to WOFT’s training facility, creating an environment where instructors, methodologies, and technologies can be combined through realistic, scenario-based exercises.

“Real-world scenario training should not be limited to law enforcement,” Novick said, pointing to potential applications involving teachers, security professionals, military personnel, and other groups responsible for protecting themselves or others.

WRAP is also developing the infrastructure needed to support that expansion. Introduced as part of the WrapShield(TM) architecture, Wrap Tactics(TM) is intended to make training more consistent, measurable, certifiable, and auditable while supporting continued learning beyond a single in-person session.

That creates a potentially important distinction for WRAP. Rather than relying solely on individual training engagements, a digital learning infrastructure could allow the company to maintain longer-term relationships with organizations through recurring education, proficiency development, and certification.

The concept also fits into WRAP’s broader vision for integrated public safety capabilities. Its WrapShield(TM) platform brings together detection, orchestration, and response capabilities, while training provides the human component needed to help personnel interpret situations, make informed decisions, and effectively utilize available technologies. In this framework, training becomes more than a standalone service; it becomes an important layer connecting people, technology, and response.

Recent expansion into private security further demonstrates the potential reach of this approach. By extending its technology, training, and operational methodologies into new customer environments, WRAP is working to demonstrate that capabilities developed for law enforcement can be adapted to a wider range of organizations facing evolving safety requirements.

For investors, the opportunity may therefore be less about any single training contract and more about whether WRAP can turn its existing expertise into a repeatable platform serving multiple markets. Education, private security, military applications, and other professional environments could provide avenues for expansion, while digital training and certification may create additional opportunities for recurring engagement.

As Novick explained, “We believe the future of training is integrated,” bringing together instructors, methodology, real-world scenarios, continuous digital learning, and technology.

The WOFT initiative may therefore represent more than a single training engagement. It provides a tangible example of how WRAP can leverage its public safety expertise and training infrastructure across new markets while building toward a more integrated technology and learning platform.

As WRAP continues connecting training, technology, situational awareness, and response capabilities, its ability to scale that integrated model across different customer groups could become an increasingly important component of the company’s broader growth story.

For more information, visit the company’s website at wrap.com.

NOTE TO INVESTORS: The latest news and updates relating to WRAP are available in the company’s newsroom at ibn.fm/WRAP

About / Disclaimer

This article was produced by IBN Editorial Staff and is intended for informational purposes only. It is not investment advice and should not be relied upon as the basis for any investment decision. Statements attributed to Wrap Technologies Inc. or its management, including any forward-looking statements regarding revenue growth, product development, or market opportunities, reflect the company’s views and are subject to risks and uncertainties; actual results may differ materially. Readers should conduct their own due diligence and consult a qualified professional. Additional company information is available at wrap.com.

• TechForce Robotics uses AI-enhanced automation to help businesses address labor shortages, rising costs and operational inefficiencies.
• Its Robotics-as-a-Service Provider (“RaaSP”) model lowers barriers to adoption while creating potential recurring revenue opportunities.
• A potential deployment of up to 5,000 robotic systems with NBR Intelligence signals TechForce’s growing ambitions in industrial and factory automation.

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, is positioning itself among the several trends reshaping the global economy: persistent labor shortages, rising operating costs and accelerating adoption of AI-enhanced automation.

Global industrial robot installations reached 542,000 units in 2024, more than double the figure recorded a decade earlier, highlighting the growing role automation is playing in addressing workforce and productivity challenges. As the industry evolves, the opportunity is increasingly shifting from technological demonstrations to robots capable of performing reliably in real operating environments (ibn.fm/XvEVP).

TechForce Robotics is building its strategy around that transition. The company develops and integrates AI-enhanced robotics solutions across hospitality, food service, commercial and industrial applications, helping operators address repetitive tasks, workforce constraints and operational bottlenecks.

A core part of that strategy is Robotics-as-a-Service Provider (“RaaSP”). Rather than requiring customers to make large upfront investments in robotic equipment, the model is designed to provide deployment, maintenance and ongoing optimization through an extended service relationship. For TechForce, that approach can also create opportunities for recurring revenue as robotic systems remain under service agreements.

The company’s focus on real-world implementation is particularly relevant as robotics adoption accelerates. The International Federation of Robotics has observed that AI-enabled robots are increasingly moving beyond prototypes and into real-world deployment, placing greater emphasis on reliability, efficiency and measurable operational performance.

TechForce recently highlighted that deployment-focused strategy through a letter of intent with Singapore-based NBR Intelligence Pte. Ltd. The nonbinding framework contemplates a potential multi-site factory automation program involving up to 5,000 robotic systems, beginning with five initial pilot systems.

The proposed program would integrate TechForce’s AI-enhanced robotic systems with NBR’s MIDAS industrial intelligence platform, which is already deployed in live factory environments. Before any broader rollout, the companies plan to conduct operational, safety, network, facility and workflow assessments, followed by pilot evaluations against agreed-upon performance criteria. The proposed quantities and deployment schedule remain subject to site identification, pilot acceptance, financing and definitive agreements.

The contemplated rollout would begin with five pilot systems, with aggregate pilot pricing currently estimated at $250,000 to $350,000, including implementation services and initial nonrecurring engineering. If the pilots are successfully completed and accepted, the framework contemplates an initial scaled deployment of 100 cumulative systems, followed by a potential rollout of approximately 500 additional systems per month until the contemplated quantity is reached. The proposed figures are planning estimates and do not represent purchase orders, backlog or guaranteed revenue.

The workforce challenge behind the opportunity is substantial. NBR Intelligence CEO Rick Nguyen said “factories on the company’s network face staffing shortages, with annual turnover running at approximately 15% to 20%. For operators confronting persistent workforce constraints, automation can provide a way to increase production capacity while shifting human workers toward roles involving robot design, installation, programming and maintenance.”

“We are excited about the potential of this project,” said Jimmy Chan, CEO of Nightfood Holdings. “In addition to helping prospective site operators address ongoing labor shortages and production constraints, the contemplated automation program is designed to materially expand production capacity and create additional revenue opportunities for the targeted operations.”

For investors, the broader opportunity may lie in TechForce’s evolving deployment model. The company is pursuing applications across multiple service-intensive and industrial markets while emphasizing structured testing, systems integration and scalable deployment rather than technology development alone.

As labor shortages continue pushing businesses toward automation, companies capable of putting AI-enhanced robotics into work in real operating environments could benefit from expanding demand. TechForce Robotics is positioning its technology, RaaSP model and growing industrial ambitions to participate in that transition, with the NBR framework providing a potential pathway from pilot deployments toward larger-scale automation.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• The Texatron(TM) program has moved from prototype development into active testing, with the company reporting continued work on its 500 kW and 5 MW configurations.
• The company says repeatable pulsed magnetic-confinement tests have produced peak pressures of approximately 100,000 atmospheres, an experimental result that it is using to advance its deuterium–helium-3 (D–³He) fusion work.
• American Fusion(TM) is targeting D–³He fusion and is developing a pulsed magnetic-compression architecture rather than a conventional steady-state magnetic-confinement system.
• The company’s 5 MW pre-production Texatron(TM) has progressed through testing at Texas Tech University, following Texas regulatory approval for the company’s research systems.
• Harbinger Research has updated its coverage of American Fusion(TM), highlighting the transition into active testing, 100 pending U.S. patent applications, the OTCQB listing, and potential future technical and commercial milestones.

American Fusion(TM) (OTCBQ: AMFN), a developer of next-generation fusion energy technologies, is entering a more consequential phase of its fusion program as recent testing updates coincide with new equity research coverage examining the company’s progress toward commercial validation.

The Southlake, Texas-based company announced recently that its Texatron(TM) Fusion Engine(TM) development program had continued to produce repeatable magnetic-confinement results, including peak confinement pressures of approximately 100,000 atmospheres (https://ibn.fm/ITBKg). The company is now working to characterize the combination of temperature, density and confinement time required to advance toward D–³He fusion conditions.

The announcement was followed by an updated research report from Harbinger Research titled “Advancing Modular Fusion Power Toward Commercial Validation.” The report represents an update to Harbinger’s January coverage and assesses American Fusion’s development over the intervening eight months (https://ibn.fm/vnw6E).

The timing is significant because American Fusion(TM) has spent much of 2026 moving the Texatron(TM) from an engineering concept toward an instrumented testing program. In June, the company took delivery of its 5 MW pre-production Texatron(TM). By late July, testing had begun at Texas Tech University, where the company’s technical team carried out laboratory preparation and system evaluations. The initial phase was completed July 31.

The company had also received a Texas Department of State Health Services Certificate for Industrial Radiation Machines covering its registered Texatron(TM) research systems. That authorization supported research and development activities at the company’s testing location in Lubbock, Texas.

American Fusion(TM) is pursuing D–³He fusion, in which deuterium and helium-3 are intended to fuse and produce energetic charged particles. Its Texatron(TM) architecture uses short-duration electromagnetic pulses to compress and heat plasma rather than relying on the large, continuous magnetic fields associated with conventional tokamak-style systems.

The company says the approach is intended to bring temperature, pressure and density together with sufficient confinement time during the pulse. Its latest calculations examine two geometries: an approximately 11-inch chamber associated with a 500 kW development model and a 23-inch chamber associated with the approximately 5 MW configuration. Under the company’s modeled assumptions, the larger configuration contains substantially more plasma volume and therefore could support a greater quantity of reacting fuel if equivalent plasma conditions can ultimately be achieved.

American Fusion(TM) explicitly distinguishes modeled fusion reactions and instantaneous energy calculations from measured fusion output, net energy gain or continuous electrical generation. A successful fusion device must demonstrate that the relevant plasma conditions can be created and sustained sufficiently for fusion reactions to occur at useful rates, while managing energy losses. Achieving a particular pressure or temperature in isolation would not establish ignition.

That scientific distinction is also central to the updated Harbinger coverage. According to American Fusion(TM), the research report examines the company’s Texatron(TM) technology, testing program, intellectual-property portfolio, commercial strategy, capital structure and competitive environment. It also points to potential future catalysts including additional testing results, evidence of D–³He fusion, quantitative energy and power measurements, repeatability, independent validation and commercial agreements.

The report comes as the company says its U.S. patent portfolio has reached 100 pending applications. American Fusion(TM) has also advanced to the OTCQB Venture Market and established SEC-reporting status, developments that increase the amount of corporate and technical information available to public-market investors.

American Fusion(TM) also sees a commercial distinction in its proposed use of aneutronic fusion. Traditional fusion concepts generally seek to heat plasma and extract energy through a thermal cycle. The Texatron(TM) concept is intended to work with charged fusion products that could, in principle, be converted directly into electricity through electromagnetic systems rather than first producing steam to drive a turbine.

The company’s technology materials describe a modular architecture intended for applications ranging from distributed power to larger industrial and utility installations. That commercial ambition places the company in a market shaped by growing electricity requirements from data centers, advanced computing, industrial electrification and other power-intensive applications.

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://ibn.fm/AMFN

• Earth Science Tech has made meaningful progress over the last few years, building a business anchored in a conglomerate model, infrastructure as a service, and end-to-end vertical integration
• The company is focused on the seamless integration of patient care through its operating businesses that offer telemedicine and telehealth infrastructure for consultations and third-party providers, compounding services, and fulfilment
• ETST has leveraged vertical integration to not only support the operations of its businesses but also tap into both B2B and B2C segments for revenue and growth

Earth Science Tech (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, began the current fiscal year 2027 in a position of real financial strength, according to CEO and Board Chairman Giorgio R. Saumat letter to shareholders (https://ibn.fm/NC6CW). This position is the result of meaningful progress over the last several years, which built a business that is not only durable, self-sustaining, and positioned for long-term growth but also anchored in a conglomerate model, infrastructure as a service, and end-to-end vertical integration.

The company’s core value proposition is the seamless integration of patient care, from consultation (through telemedicine and telehealth platforms) and clinical support to compounding pharmacy operations and direct-to-patient fulfillment. The company provides this value through its operating businesses, which are strategically and vertically integrated: RxCompoundStore.com LLC (“RxCS”), Mister Meds LLC, Zoolzy LLC, Meduvo LLC, Peaks Curative LLC (“Peaks”), DOConsultation.com LLC (“DOC”), Las Vilas Health Care, Avenvi LLC, and MagneChef.

RxCS is a Miami-based licensed pharmacy that compounds sterile and non-sterile medication, while Mister Meds is an Abilene-based pharmacy that compounds sterile drugs and is licensed to handle hazardous drugs. Meduvo is Earth Science Tech’s recently acquired La Verne-based compounding pharmacy that makes and dispenses non-sterile medication. Combined, these compounding pharmacies are licensed in 34 jurisdictions in the United States (https://ibn.fm/Kw23s).

Earth Science Tech recently completed the acquisition of Zoolzy, a Doral-based wholesale distributor of active pharmaceutical ingredients (“APIs”) and finished FDA-approved prescription products (https://ibn.fm/hHh5K). The acquisition taps into a new vertical and enables the company’s compounding pharmacies to secure essential raw materials at competitive wholesale prices, thus supporting ETST’s strategy to vertically integrate its operations end-to-end.

The vertical integration strategy is also evident in the operations of other subsidiaries, including Peaks and DOC. Peaks is a telemedicine referral platform that offers asynchronous consultation for compounded drugs, while DOC is a telehealth brand through which a team of medical experts offers virtual consultations and treatments, with prescriptions fulfilled by ETST’s compounding pharmacies.

Besides supporting vertical integration, the company’s telehealth and telemedicine platforms and compounding pharmacies serve a second purpose: they ensure that ETST not only sells products to consumers but also provides medical consultation tech infrastructure and compounding services to third-party providers and companies. As a result, ETST generates high-margin B2B revenue to supplement B2C revenue from consumers.

Earth Science Tech continues to leverage its conglomerate model, infrastructure-as-a-service, and vertical integration as well as optimized operational frameworks to drive growth and support scalable, sustainable expansion. And as Mr. Saumat stated in his letter, management expects “every company under the ETST umbrella to expand its geographic footprint this year” and that the company “will pursue acquisitions and/or partnerships where they help us meet that goal.” 

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST 

• The company’s original flagship asset is Skaergaard, a palladium-gold-platinum deposit in southeast Greenland.
• Greenland Mines has completed its acquisition of Neo North Star Resources Inc., bringing the Sarfartoq rare earths project in southwest Greenland into the company’s portfolio.
• Both projects sit inside Greenland, a jurisdiction the company describes as mining friendly, with a modern regulatory regime and no third-party royalties layered onto either asset.

Junior mining stocks live and die by a single number: The price of whatever metal sits beneath their flagship projects. When that price falls, so does the company, regardless of how good the geology is. It is a structural weakness baked into most explorers’ business models, and it explains why single-asset miners trade at a discount and swing wildly with commodity headlines. Greenland Mines (NASDAQ: GRML) is ensuring it doesn’t operate in that space, having transformed from a company built around one palladium-gold-platinum deposit into one that now also controls a major rare earths project, a shift that creates a different view for interested investors.

The company’s original flagship asset is Skaergaard, a palladium-gold-platinum deposit in southeast Greenland. An updated 2026 mineral resource estimate, prepared by independent consultant SLR Consulting under the SEC’s S-K 1300 disclosure standard, put indicated resources at 15.0 million ounces of palladium-equivalent metal. Inferred resources came in at 17.49 million ounces, figures the company describes as making Skaergaard one of the largest undeveloped deposits of its kind. That is a substantial, de-risked technical foundation. But it is also, by definition, a bet on three closely related metals whose prices tend to move together through industrial and precious metals cycles.

That single-metal-family concentration is exactly what Greenland Mines set out to address next. Earlier this year,Greenland Mines signed a definitive agreement to acquire Neo North Star Resources Inc., and on September 1, 2026, following formal approval from the government of Greenland, the acquisition closed. Neo North Star owned the Sarfartoq rare earths project in southwest Greenland, which Greenland Mines bought from stockholders including Neo Performance Materials for $20 million in cash and $15 million in securities value. 

Neo Performance Materials became a strategic shareholder of Greenland Mines as part of the deal and retains offtake rights for up to 60% of future Sarfartoq production, to be processed at its Silmet facility in Estonia. Sarfartoq is a carbonatite-hosted deposit built around neodymium and praseodymium. Those two rare earth elements go into the permanent magnets found in electric vehicle motors, wind turbines and defense systems. That is a fundamentally different commodity story than palladium and gold, driven by electrification and supply-chain policy rather than jewelry demand or catalytic converter volumes.

The distinction matters more than it might first appear. Palladium and platinum prices are closely tied to internal combustion and hybrid vehicle production, an industry facing long-term structural headwinds from electrification. Gold tends to move on interest rates, inflation expectations and safe-haven demand. Neodymium and praseodymium, by contrast, are levered to the buildout of electric motors and wind turbines, a demand curve that runs largely independent of the first two. Owning meaningful exposure to both baskets means a downturn in one commodity complex does not automatically translate into a company-wide crisis.

Geography reinforces the diversification. Both projects sit inside Greenland, a jurisdiction the company describes as mining friendly, with a modern regulatory regime and no third-party royalties layered onto either asset. That single-country footprint keeps political and permitting risk consistent across the portfolio, even as the underlying commodities diverge. It is a cleaner risk structure than juggling projects spread across multiple regulatory regimes.

There is also a policy tailwind specific to Sarfartoq that Skaergaard does not share. Global neodymium-praseodymium supply remains heavily concentrated outside the western hemisphere. Recent export restrictions have intensified pressure on the United States, Europe and allied nations to secure independent sources. Sarfartoq’s core ST1 zone carries a neodymium-praseodymium ratio of 25–40% of total rare earth oxides. That is among the highest such ratios reported anywhere in the world. That kind of concentration is unusual, giving the project relevance to western critical-minerals policy that a pure precious-metals deposit does not carry on its own.

None of this eliminates the risks inherent to early-stage mining companies. With the Sarfartoq acquisition now closed, Greenland Mines moves from deal-making to execution, advancing the project toward a prefeasibility study through infill drilling, metallurgical test work and continued permitting. Both projects still need time before production, with resource figures not yet showing economic viability. Commodity diversification reduces single-metal exposure; it does not remove risk.

Still, the strategic logic is straightforward. A company holding two projects across two distinct commodity cycles, inside one stable jurisdiction, offers a different risk-reward proposition than a peer betting everything on a single metal’s next price cycle. For a small-cap miner, that kind of structural diversification is not something investors can build for themselves by holding one stock. It has to be built into the company itself, and Greenland Mines has spent this year doing exactly that.

For more information, visit www.GreenlandMines.com.

NOTE TO INVESTORS: The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. 

• The company’s Cameron field exploration program was designed to refine previously identified REE geochemical anomalies and improve the definition of potential bedrock source areas.
• Powermax collected 250 samples, including rock-chip, soil and stream-sediment samples, with laboratory results now pending.
• Cameron adds another exploration opportunity to Powermax’s broader portfolio of rare-earth projects in Canada and the United States.
• Growing demand for rare earth elements, combined with China’s dominant position in processing and continuing export restrictions, is increasing the strategic importance of alternative supply.
• The next important catalyst for Powermax will be the release and interpretation of the 2026 Cameron analytical results, while the project remains at an early exploration stage.

Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company, has completed its 2026 field exploration program at the Cameron Rare Earth Element Project in British Columbia, moving the project into an important analytical phase as investors continue to focus on the global shortage of non-Chinese critical-mineral supply.

The July-August campaign produced a substantial new dataset. Powermax collected 250 samples across priority areas of the approximately 2,984-hectare Cameron project, including 50 rock-chip samples, 50 soil samples and 150 stream-sediment samples. All samples have been submitted to AGAT Laboratories in Calgary for analysis. The company said results will be released after they are received and subjected to its quality-control and quality-assurance review (https://ibn.fm/1deMT). 

Previous exploration identified REE geochemical anomalies at Cameron. Those results, together with mapped pegmatite occurrences and historical mineral occurrences helped determine where Powermax concentrated its 2026 work. The latest campaign was designed to improve the geological picture and identify potential bedrock source areas that could warrant additional investigation.

Field teams documented a range of rock types during the campaign, including gneissic and granodioritic rocks, quartzite, pegmatitic material and quartz-veined or contact-zone material. Quartz, feldspar, biotite and muscovite were commonly recorded, along with localized oxidation and iron staining.

Those observations are useful for geological interpretation, but they should not be confused with assay results. Field descriptions alone cannot establish REE grades or economic significance. The same caution applies to handheld radiometric readings taken at selected locations. The measurements were used as field-screening information to assist mapping and sample selection rather than as direct determinations of REE concentrations.

The company’s earlier work provides the context for the new campaign. Powermax reported REE anomalies from soil and stream-sediment sampling earlier in 2026, leading to additional investigation of priority areas. The new samples now provide an opportunity to test those areas with a broader and more systematic dataset.

The next step is therefore straightforward but potentially important: laboratory assays will determine whether the geological observations and previous anomalies are supported by meaningful concentrations of rare earth elements.

That exploration work is taking place against a backdrop of increasing concern over the structure of the global rare-earth supply chain. Rare earth elements are essential inputs for permanent magnets used in numerous advanced technologies. The most commercially significant magnetic REEs include neodymium and praseodymium, with dysprosium and terbium also important where high-temperature performance is required.

Demand is expected to rise sharply over the coming decade. McKinsey has estimated that demand for magnetic rare earths could increase from approximately 59,000 tonnes in 2022 to 176,000 tonnes by 2035. The same analysis indicated that the currently announced project pipeline could leave the market with a potential supply shortfall.

That imbalance has consequences well beyond the mining industry. China remains the dominant participant in the rare-earth supply chain, particularly in processing. Beijing has also imposed export controls affecting several critical rare-earth materials, highlighting the vulnerability of manufacturers that depend on concentrated overseas supply chains.

For the United States and its allies, developing alternative sources is increasingly viewed as a strategic requirement rather than simply a commodity-market opportunity. The U.S. government has consequently been directing substantial funding toward domestic critical-mineral and magnet supply chains. Canadian projects can potentially benefit from this policy environment because of the close integration between the two countries’ mineral and manufacturing industries.

Cameron is not Powermax’s only exposure to the rare-earth opportunity. The company also has interests in the Atikokan, Hopkins and Pinard REE properties in Ontario, while its Ogden Bear Lodge Project in Wyoming is held 100%. That geographic diversification gives investors exposure to exploration opportunities on both sides of the Canada-U.S. border.

Ogden Bear Lodge is particularly interesting from a strategic perspective because it is located in Crook County, Wyoming, adjacent to the Bear Lodge Critical Rare Earth Project being advanced by Rare Element Resources.

For more information, visit the company’s website at www.PowermaxMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to PWMXF are available in the company’s newsroom at https://ibn.fm/PWMXF

Investor conferences can take a lot of different forms. Some lean heavily toward networking, while others focus primarily on company presentations and scheduled investor meetings.

The Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference falls into the latter category. Organized by an investment bank, the two-day event is designed to bring emerging and under-covered companies together with investors actively looking for opportunities in the small- and mid-cap markets.

Moody Capital Solutions is an investment bank with a roughly 40-year history and offices in Alpharetta, Georgia, and at 230 Park Avenue in New York. A FINRA and SIPC member, the firm provides capital raising, M&A and advisory services to public and private companies, with a focus that includes life sciences, technology and healthcare. In February 2025, Moody Capital consolidated its Capitalyst division into the parent firm, expanding its investment banking capabilities.

That background helps explain the structure of the conference. Rather than building the agenda around broad industry discussions, much of the programming focuses on issues that emerging companies and their investors are dealing with now: raising capital, accessing the public markets, maintaining a listing and connecting directly with potential investors.

Chairman and CEO Richard H. Kreger has framed the 2026 conference around two areas experiencing particularly strong activity. He noted that “artificial intelligence has lit a fire for quickly scaling emerging growth companies,” while life sciences is seeing “unprecedented growth amid a spike of FDA approvals, corporate buyouts and deregulation.”

Those themes form the conference’s two primary tracks, which will run concurrently across both days.

The life sciences track includes biotechnology, medical devices, pharmaceuticals, healthcare technology and diagnostics. Confirmed presenters include American Gene Technologies, BiovaXys, Citius Pharmaceuticals, CytoSorbents, GT Biopharma, ProMIS Neurosciences, Soligenix and NurExone Biologic.

The disruptive growth track focuses on technology, energy and infrastructure. Presenting companies include AIB Data Centers, Axe Compute, Bit Digital, Century Lithium, Eco Wave Power, NeoVolta, Ocean Power Technologies, Interlink Electronics, Intrusion Inc., AmpliTech, U.S. Gold Corp and GPO Plus, among others.

More than 50 companies are scheduled to present in total, with presentations delivered in person by members of their executive teams. NeoVolta’s Wednesday, September 9 presentation, for example, is scheduled for 4:05 p.m. ET and will be led by CEO Ardes Johnson.

Alongside the two primary tracks, the conference will also feature a dedicated Mr. Crowd(R) crowdfunding track for private companies raising capital.

That gives investors another category of companies to explore during the event. Most small-cap investor conferences are centered on publicly traded companies. Here, attendees will also have access to private companies that may be at an earlier point in the capital-raising process.

For family offices and accredited individual investors, both of which are part of the conference’s intended audience, having public and private opportunities available at the same event broadens the range of companies they can evaluate.

Presentations are only one part of the two-day schedule. The announced agenda also includes:

• One-on-one investor meetings scheduled through the conference platform and held throughout both days
• Executive fireside chats offering longer, moderated conversations with management teams
• Capital markets outlook panels focused on the current financing environment
• Panels on going public and remaining listed, including discussions around uplisting, compliance and maintaining a public listing
• Networking receptions bringing company executives together with institutional investors, family offices and other attendees

The mix of programming reflects the two groups the conference is designed to bring together. Company executives have access to discussions about financing and navigating the public markets, while investors have dedicated time for presentations, one-on-one meetings and direct conversations with management.

Investor registration and one-on-one scheduling are handled through the MeetMax platform. Registered investors can attend company presentations and request individual meetings with participating management teams.

In late August, Moody Capital engaged IBN (InvestorBrandNetwork) as the conference’s official media partner.

IBN will support the event through article syndication, press release distribution and social media amplification across a network that includes more than 70 branded properties, over 2 million social media followers and more than 5,000 syndication partners.

For presenting companies, that creates opportunities for conference-related announcements and coverage to reach audiences beyond those attending in New York. It also gives investors another way to follow company news and conference developments before, during and after the event.

The format is fairly straightforward: two days, two primary tracks, more than 50 presenting companies, a private-company crowdfunding track and dedicated time for one-on-one investor meetings.

The focus throughout is direct access. For emerging companies, that means getting in front of investors who may not otherwise encounter their stories through traditional research coverage. For investors, it means being able to hear directly from management, ask questions and compare a large number of opportunities in a relatively short period of time.

With both biotech and AI-related infrastructure attracting significant investor attention in 2026, the timing gives those conversations additional relevance.

Getting the most out of the conference will ultimately come down to preparation: identifying the companies worth seeing, requesting the right meetings and deciding which presentations warrant a closer look after everyone leaves the Westin.

To register to attend the 2026 Disruptive Growth & Life Sciences Conference, visit: https://moodycapital.com/conference/

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) and may include paid advertising.

• Investors in biotechnology often look for companies with a clear path toward clinical development, where regulatory preparation, manufacturing readiness and access to capital can help reduce execution risk.
• Onco-Innovations Ltd. is advancing ONC010, a nanoparticle-encapsulated PNKP inhibitor designed to target DNA repair pathways involved in cancer survival and treatment resistance.
• The company has strengthened its clinical foundation through manufacturing milestones, IND-enabling activities, strategic partnerships and a recent funding arrangement designed to support continued advancement of its oncology pipeline.

For biotechnology investors, a clear path to the clinic can be one of the most important indicators of a company’s development potential. In oncology, where programs often face significant scientific, regulatory and financial hurdles, companies that demonstrate measurable progress across manufacturing, preclinical testing and operational execution may be better positioned to advance promising therapies.

Beyond scientific validation, access to capital is another critical component of clinical development. Drug candidates require substantial resources to move from discovery through regulatory milestones and into human studies, making strategic financing an important factor in sustaining momentum.

This combination of scientific progress and operational execution is particularly important in oncology, where therapies addressing difficult-to-treat cancers and treatment resistance can represent significant opportunities if successfully developed.

One company working to advance this transition is Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H), a preclinical-stage precision oncology company focused on developing therapies targeting DNA Damage Response (“DDR”) pathways.

The company’s lead candidate, ONC010, is a nanoparticle-encapsulated Polynucleotide Kinase Phosphatase (“PNKP”) inhibitor designed to interfere with DNA repair mechanisms that cancer cells rely on for survival and resistance.

Building the Foundation for Clinical Development

Onco-Innovations has recently achieved several milestones designed to support the continued development of ONC010. The company completed a successful 300-gram active pharmaceutical ingredient (“API”) scale-up, achieving approximately 99.3% purity with residual solvents below the limits of detection of the analytical methods employed, representing an important step toward establishing scalable manufacturing capabilities.

The company has also expanded its manufacturing and formulation capabilities through strategic collaborations, including its partnership with Nanosoft Polymers to support the development, optimization and scaling of the polymer manufacturing process used for ONC010.

Additional development activities include metabolism studies, analytical characterization, exclusive licensing agreements supporting intellectual property protection, and other IND-enabling studies designed to advance the program toward regulatory submission.

Capital Formation Supports Continued Advancement

Alongside these scientific and manufacturing milestones, Onco-Innovations has continued strengthening the financial foundation needed to support its clinical strategy.

The company recently announced an institutional funding arrangement representing a notional subscription amount of approximately CAD$5 million. The financing structure is intended to support key development priorities, including advancing ONC010 through manufacturing and preclinical activities, further development of the SynoGraph(TM) platform, and general corporate purposes.

For emerging biotechnology companies, securing capital ahead of major clinical milestones can be an important step in maintaining development timelines. The arrangement is structured to release proceeds across eighteen monthly tranches against a benchmark price, so the amount ultimately realized may be more or less than the notional subscription amount. By combining this financing structure with continued progress across manufacturing and IND-enabling activities, Onco-Innovations is working to establish the infrastructure needed to support its transition toward human trials.

Preparing for the Next Stage

Onco-Innovations has also strengthened its leadership team with the appointment of Dave Antony as Chief Financial Officer. Antony brings more than 35 years of experience spanning financial planning, reporting, corporate finance, governance and public company advisory matters.

With manufacturing advancements, regulatory preparation, strategic partnerships and a financing structure in place, Onco-Innovations is continuing to build the foundation required for the next stage of ONC010 development, which includes the continuation of its IND-enabling studies in support of a planned Phase 1 program in Australia.

For more information, visit https://oncoinnovations.com.

NOTE TO INVESTORS: The latest news and updates relating to ONNVF are available in the company’s newsroom at ibn.fm/ONNVF

• The current geopolitical disruption has exposed what energy analysts have long documented: The United States, despite being one of the world’s largest oil producers, still imports approximately 6.3 million barrels of crude oil per day.
• Frontieras is building a processing infrastructure to convert coal, a resource abundant in the United States, into the fuels and materials that American industry and transportation actually need.
• Frontieras is advancing its proprietary model from concept to construction.

Recent world geopolitical events have made one argument impossible to dismiss: Energy systems built around imported feedstocks and foreign supply chains carry risks that domestic production does not. Frontieras North America is working to strengthen its position in that domestic alternative, creating a production system that converts American coal into six essential byproducts, all within U.S. infrastructure and using a feedstock that never crosses a border or passes through a maritime chokepoint.

The scale of the current disruption is significant. When the United States and Israel launched strikes on Iran in late February 2026, Iran responded by effectively closing the Strait of Hormuz, the world’s most critical oil shipping passage. Reports confirmed the strait was functionally closed to commercial traffic, with insurance unavailable and crews unwilling to make the transit, describing it as potentially the greatest global energy supply shock in decades. Brent crude prices surged past $115 per barrel in early March, a 24% single-session increase, as the strait closure removed an estimated 15 million barrels of daily supply from global markets.

The disruption exposed what energy analysts have long documented: The United States, despite being one of the world’s largest oil producers, still imports approximately 6.3 million barrels of crude oil per day. The reason is structural. American refineries, particularly along the Gulf Coast, are configured to process heavy, sour crude — the kind produced in the Middle East and Venezuela — rather than the light, sweet crude that domestic shale fields produce in abundance. That mismatch means U.S. fuel production remains tethered to global crude markets and the shipping routes that connect them, even as domestic production hits record levels.

The Congressional Research Service noted that congressional concern had risen sharply following the February–March 2026 conflict, with oversight hearings focused on what a prolonged strait closure would mean for U.S. oil, gas and commodity prices. The answer, as markets demonstrated, is that it means severe and rapid price spikes across fuels, fertilizers and industrial inputs, a chain of disruption that reaches every sector of the American economy.

Coal does not travel through the Strait of Hormuz. It does not pass through any foreign port or foreign supply chain. The United States holds approximately 468 billion short tons in demonstrated coal reserves, a domestic resource base larger than remaining U.S. oil and gas reserves combined when measured by energy content. Annual production runs at roughly 500 million short tons. That resource sits entirely within U.S. territory, priced in domestic markets, and accessible without import logistics of any kind.

Frontieras is building the processing infrastructure to convert that resource into the fuels and materials that American industry and transportation actually need. Its FASForm(TM) process applies continuous thermal cracking and distillation to coal without combustion, separating it into six commercial products: ultra-low sulfur diesel, naphtha, jet fuel, FASCarbon(TM), ammonium sulfate fertilizer and sulfuric acid. No foreign feedstock enters the process. No overseas facility touches the output.

The coal feedstock behind FASForm also carries a structural pricing advantage. According to the IEA’s Coal 2025 analysis, “coal markets have shown more predictable and subdued price movements” compared to natural gas and crude oil, which “continue to be influenced by geopolitical risks and supply-side uncertainties.” The EIA similarly notes that coal contract prices tend to be more stable than those of other energy commodities. That means a coal-to-fuels system anchored to domestic inputs improves its margins in precisely the conditions, including geopolitical disruption and supply chain stress, that drive oil prices higher.

Frontieras is advancing its proprietary model from concept to construction. Its flagship Mason County, West Virginia facility, announced with an $850 million investment commitment and the backing of West Virginia Governor Patrick Morrisey, will process 7,500 tons of coal per day when operational. It will be powered predominantly by the hydrogen its own process generates, making it one of the first large-scale industrial plants in the United States to run on its own hydrogen output.

The energy disruptions of 2026 have compressed what was once a long-term policy debate into an immediate operational question: Where does American fuel come from when the global supply chain breaks down? Frontieras is building an answer to that question: a domestic production system that draws on the country’s most abundant energy resource and delivers the fuels and industrial materials that the economy runs on, without a single foreign input in the chain.

For more information about Frontieras, visit the company’s website at www.Frontieras.com.

NOTE TO INVESTORS: The latest news and updates relating to Frontieras are available in the company’s newsroom at https://ibn.fm/Frontieras